Tumor-Derived Exosomal miR-620 as a Diagnostic Biomarker in Non-Small-Cell Lung Cancer.

Youyong TangZhijun ZhangXingguo SongMiao YuLimin NiuYajing ZhaoLi WangXianrang SongLi Xie

Published in: Journal of oncology (2020)

These findings suggest the serum exosomal miR-620 as a promising diagnostic and prognostic noninvasive biomarker in NSCLC patients.

Keyphrases